BioSpace News Archive

Anchiano Therapeutics Ltd. announced it has elected to hold its 2020 Annual General Meeting of Shareholders as a virtual meeting due to the ongoing public health concerns related to the coronavirus pandemic.

Crinetics Pharmaceuticals, Inc. announced that it has closed its previously announced underwritten public offering of 8,222,500 shares of its common stock, including 1,072,500 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a price to the public of $14.00 per share.

Kala Pharmaceuticals, Inc., announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.

Baxter International Inc., a leading global medical products company, will host a conference call to discuss its first-quarter 2020 financial results on Thursday, April 30, 2020, at 7:30 a.m. Central Time..

The Government of Canada is taking action to help Canadian businesses and organizations keep their doors open, keep their employees on the payroll, and recover quickly when Canada bounces back from this crisis.

The Canadian Medical Association is pleased to announce a multi-year investment of $500,000 to increase palliative care training during the COVID-19 pandemic and beyond.

The American Diabetes Association® applauds the Washington governor and legislature for passing SB 6087

Immunic, Inc. announced a series of changes to its Executive Team, including the departure of Chief Financial Officer, Sanjay S. Patel, CFA, who has resigned to pursue opportunities in the nonprofit sector.

Answering the call for additional medical workers to join the frontlines of the COVID-19 pandemic, more than 100 medical students at Albert Einstein College of Medicine graduated a month early.

Oncolytics Biotech® Inc. provided an update on the potential impact of COVID-19 on the Company’s clinical and business operations.